Owner Nissan Chemical Industries, Ltd.

Inventors Horikawa, Masato; Ishiwata, Norihisa; Shigeta, Yukihiro; Nakano, Satoshi; Miyaji, Katsuaki; Hirokawa, Yutaka; Toyama, Koji; Ota, Hirofumi; Yanagihara, Kazufumi; Iwamoto, Shunsuke; Owada, Shingo

Agent Davies Collison Cave

Pub. Number AU-B-2005314788

PCT Pub. Number WO2006/064957

Priority 2004-361750 14.12.04 JP; 2005-134643 02.05.05 JP

Filing date 14 December 2005

Wipo publication date 22 June 2006

Acceptance publication date 22 September 2011

C07D 231/18 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

A61K 31/381 (2006.01) - having five-membered rings

A61K 31/4025 (2006.01) - not condensed and containing further heterocyclic rings, e.g. cromakalim

A61K 31/415 (2006.01) - 1,2-Diazoles

A61K 31/4155 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/4436 (2006.01)

A61K 31/4535 (2006.01)

A61K 31/5377 (2006.01)

A61P 7/04 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07D 333/32 (2006.01) Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

C07D 409/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 409/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms